These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1110 related items for PubMed ID: 18571892

  • 1. Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitro.
    Yanagie H, Hisa T, Ogata A, Miyazaki A, Nonaka Y, Nishihira T, Osada I, Sairennji T, Sugiyama H, Furuya Y, Kidani Y, Takamoto S, Takahashi H, Eriguchi M.
    Biomed Pharmacother; 2009 Sep; 63(8):553-60. PubMed ID: 18571892
    [Abstract] [Full Text] [Related]

  • 2. Oxaliplatin in treatment of the cisplatin-resistant MKN45 cell line of gastric cancer.
    Tozawa K, Oshima T, Kobayashi T, Yamamoto N, Hayashi C, Matsumoto T, Miwa H.
    Anticancer Res; 2008 Sep; 28(4B):2087-92. PubMed ID: 18751380
    [Abstract] [Full Text] [Related]

  • 3. Analysis of gene expression profiles associated with cisplatin resistance in human ovarian cancer cell lines and tissues using cDNA microarray.
    Sakamoto M, Kondo A, Kawasaki K, Goto T, Sakamoto H, Miyake K, Koyamatsu Y, Akiya T, Iwabuchi H, Muroya T, Ochiai K, Tanaka T, Kikuchi Y, Tenjin Y.
    Hum Cell; 2001 Dec; 14(4):305-15. PubMed ID: 11925933
    [Abstract] [Full Text] [Related]

  • 4. Altered expression of gamma-glutamylcysteine synthetase, metallothionein and topoisomerase I or II during acquisition of drug resistance to cisplatin in human ovarian cancer cells.
    Kikuchi Y, Hirata J, Yamamoto K, Ishii K, Kita T, Kudoh K, Tode T, Nagata I, Taniguchi K, Kuwano M.
    Jpn J Cancer Res; 1997 Feb; 88(2):213-7. PubMed ID: 9119751
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Reversal of multidrug resistance by small interfering double-stranded RNAs in ovarian cancer cells.
    Zhang T, Guan M, Jin HY, Lu Y.
    Gynecol Oncol; 2005 May; 97(2):501-7. PubMed ID: 15863151
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Gene expression profiles with cDNA microarray reveal RhoGDI as a predictive marker for paclitaxel resistance in ovarian cancers.
    Goto T, Takano M, Sakamoto M, Kondo A, Hirata J, Kita T, Tsuda H, Tenjin Y, Kikuchi Y.
    Oncol Rep; 2006 May; 15(5):1265-71. PubMed ID: 16596196
    [Abstract] [Full Text] [Related]

  • 9. Evidence for altered regulation of gamma-glutamylcysteine synthetase gene expression among cisplatin-sensitive and cisplatin-resistant human ovarian cancer cell lines.
    Yao KS, Godwin AK, Johnson SW, Ozols RF, O'Dwyer PJ, Hamilton TC.
    Cancer Res; 1995 Oct 01; 55(19):4367-74. PubMed ID: 7671249
    [Abstract] [Full Text] [Related]

  • 10. MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs.
    Chen S, Jiao JW, Sun KX, Zong ZH, Zhao Y.
    Drug Des Devel Ther; 2015 Oct 01; 9():5225-35. PubMed ID: 26396496
    [Abstract] [Full Text] [Related]

  • 11. Novel mechanisms of platinum drug resistance identified in cells selected for resistance to JM118 the active metabolite of satraplatin.
    Samimi G, Kishimoto S, Manorek G, Breaux JK, Howell SB.
    Cancer Chemother Pharmacol; 2007 Feb 01; 59(3):301-12. PubMed ID: 16770583
    [Abstract] [Full Text] [Related]

  • 12. Gene expression profiling for analysis acquired oxaliplatin resistant factors in human gastric carcinoma TSGH-S3 cells: the role of IL-6 signaling and Nrf2/AKR1C axis identification.
    Chen CC, Chu CB, Liu KJ, Huang CY, Chang JY, Pan WY, Chen HH, Cheng YH, Lee KD, Chen MF, Kuo CC, Chen LT.
    Biochem Pharmacol; 2013 Oct 01; 86(7):872-87. PubMed ID: 23933386
    [Abstract] [Full Text] [Related]

  • 13. Histone deacetylase 1 gene expression and sensitization of multidrug-resistant neuroblastoma cell lines to cytotoxic agents by depsipeptide.
    Keshelava N, Davicioni E, Wan Z, Ji L, Sposto R, Triche TJ, Reynolds CP.
    J Natl Cancer Inst; 2007 Jul 18; 99(14):1107-19. PubMed ID: 17623797
    [Abstract] [Full Text] [Related]

  • 14. Induction of gamma-glutamyl transpeptidase mRNA by platinum complexes in a human ovarian carcinoma cell line.
    el-akawi Z, Zdanowicz J, Creaven PJ, Abu-hadid M, Perez R, Pendyala L.
    Oncol Res; 1996 Jul 18; 8(10-11):415-23. PubMed ID: 9114434
    [Abstract] [Full Text] [Related]

  • 15. [Gene expression profiling of human ovarian epithelial tumors by digo nucleotide microarray].
    Konno R.
    Hum Cell; 2001 Dec 18; 14(4):261-6. PubMed ID: 11925926
    [Abstract] [Full Text] [Related]

  • 16. Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin.
    Jain N, Lam YM, Pym J, Campling BG.
    Cancer; 1996 May 01; 77(9):1797-808. PubMed ID: 8646677
    [Abstract] [Full Text] [Related]

  • 17. Enhanced expression of gamma-glutamylcysteine synthetase and glutathione S-transferase genes in cisplatin-resistant bladder cancer cells with multidrug resistance phenotype.
    Kotoh S, Naito S, Yokomizo A, Kohno K, Kuwano M, Kumazawa J.
    J Urol; 1997 Mar 01; 157(3):1054-8. PubMed ID: 9072542
    [Abstract] [Full Text] [Related]

  • 18. Enhanced expression of nuclear factor I/B in oxaliplatin-resistant human cancer cell lines.
    Kashiwagi E, Izumi H, Yasuniwa Y, Baba R, Doi Y, Kidani A, Arao T, Nishio K, Naito S, Kohno K.
    Cancer Sci; 2011 Feb 01; 102(2):382-6. PubMed ID: 21087353
    [Abstract] [Full Text] [Related]

  • 19. Inhibition by 5-fluorouracil of ERCC1 and gamma-glutamylcysteine synthetase messenger RNA expression in a cisplatin-resistant HST-1 human squamous carcinoma cell line.
    Fujishima H, Nakano S, Masumoto N, Esaki T, Tatsumoto T, Kondo T, Niho Y.
    Oncol Res; 1997 Feb 01; 9(4):167-72. PubMed ID: 9268987
    [Abstract] [Full Text] [Related]

  • 20. cDNA microarray-based identification of genes and pathways associated with oxaliplatin resistance.
    Samimi G, Manorek G, Castel R, Breaux JK, Cheng TC, Berry CC, Los G, Howell SB.
    Cancer Chemother Pharmacol; 2005 Jan 01; 55(1):1-11. PubMed ID: 15378272
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 56.